The 340B Drug Discount program continues to attract the attention of policy makers. That’s because many believe that the program has grown very fast and without appropriate oversight. This has sparked a variety of efforts…

Also in the Policy Brief:

• Efforts to Address the Opioid Crisis Continue at Full Speed
• A Look at the Federal Register